Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%
- Check19 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release with updated content. The 'Back to Top' link was removed.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has undergone significant updates, including the addition of new investigational site locations and the removal of several previous sites. Notably, the page now includes updated trial numbers and estimated last update dates.SummaryDifference4%
- Check48 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as related medical topics concerning cancer and immunotherapy. Notably, the previous versions of these locations have been removed, indicating a potential reorganization or update in the information presented.SummaryDifference19%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.